We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Innova and Mologic Sign Supply and Licensing Agreement

News   Aug 05, 2015

 
Innova and Mologic Sign Supply and Licensing Agreement
 
 
 

RELATED ARTICLES

Improving Nature’s Own Ability To Kill Dangerous Bacteria

News

The ramifications of bacteria's ability to become resistant to antibiotics can be seen in hospitals, public places, our food supply, and our water. Now, researchers have demonstrated how we could improve upon the ability of nature's exquisitely selective collection of antimicrobial enzymes to attack bacteria in a way that's much less likely to cause bacterial resistance.

READ MORE

Folding a Drop of Water Solves a Longstanding Challenge in Portable Diagnostic Devices

News

Researchers from Polytechnique and IBM “fold” a drop of water, solving a problem that has hindered the development of portable diagnostic systems.

READ MORE

“Express Courier Service” for DNA Delivery Expected to Boost Cancer Immunotherapy

News

Immunotherapy is a promising cancer treatment that uses genetically modified immune cells to fight cancer. However, the process known as transfection to generate genetically engineered immune cells in the laboratory has poor efficiency and may have serious side effects. Now, a research team has successfully invented a novel transfection method to deliver DNA into immune cells with minimal stress on these cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE